Long-Term Clinical Responses of Neoadjuvant Dendritic Cell Infusions and Radiation in Soft Tissue Sarcoma
Table 2
Common adverse events of Phase I trial combining neoadjuvant radiation and dendritic cell injections subdivided by grades 1–5 and total number of events during the course of the treatment.
